Almost a billion people between the ages of 30 and 70 are predicted to experience OSA (Obstructive Sleep Apnoea) which is a fairly common issue where the walls of the throat relax and narrow during sleep, interrupting normal breathing. The digital health company, Somne, is concentrating on solving this problem, and has publicised the fact it is in the process of creating an innovative, non-invasive substitute to continuous positive airway pressure therapy (CPAP).
The ‘neck collar’ device by Somne is designed to be worn around the patient’s neck, utilising vNEP (patented Variable Negative Pressure) tech to deliver therapy during sleep for a non- confining treatment. The model offers mild suction to stop the individual’s soft tissue from pressing on their airway. The act of keeping the airway open and reducing the weight on it supports the patient in respiring normally and having an easy sleep. A trial approved by the Institutional review board (IRB) proved that the model of the collar sleep device delivers highly effective relief.
“Somne is launching with a desire to have equal focus on patient’s comfort, adherence and efficacy“
The digital health company remains fixated on the creation of the product while initiating the FDA IDE Application. Somne aims to put its products on the market in 2024.
Sommne’s Chief Executive Officer, Volha Hrechka, said “Somne is launching with a desire to have equal focus on patient’s comfort, adherence and efficacy. We’re utilising variable negative pressure technology to develop this first of its kind medical device which reduces the discomfort that has plagued mass adoption of other sub-optimal products. Somne’s novel Class II medical device will be an alternative to CPAP machines and other treatments, with a more comfortable fit.”
Sleep expert, physician, and medical advisor at Somne, Dr. Jerry Kram, said “There are millions of people prescribed CPAP for treatment who are simply not using it. Left untreated, OSA can contribute to other serious health complications such as heart problems, high blood pressure, Type 2 diabetes, and cognitive decline. Somne’s device could be a game-changing, innovative approach for OSA management for sleep apnoea patients worldwide. A comfortable fit from a non-intrusive device will make it easier for patients to embrace treatment.”See all the latest jobs in Medical Devices